PharmaKinetics
Executive Summary
Baltimore-based clinical research firm signs $2.2 mil. product development contract and royalty agreement with "a leading generic U.S. pharmaceutical manufacturer." Agreement calls for PharmaKinetics to provide for management, design and execution of all regulatory and clinical research required to complete an ANDA for "a generic drug." Firm says "substantially all" services are to be performed over the next 18 months.